Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
Jäger W, Xue H, Hayashi T, Janssen C, Awrey S, Wyatt AW, Anderson S, Moskalev I, Haegert A, Alshalalfa M, Erho N, Davicioni E, Fazli L, Li E, Collins C, Wang Y, Black PC.
Jäger W, et al. Among authors: wyatt aw.
Oncotarget. 2015 Aug 28;6(25):21522-32. doi: 10.18632/oncotarget.3974.
Oncotarget. 2015.
PMID: 26041878
Free PMC article.